van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem. Biol. Interact.
2000;129:61-67.
Backman JT, Granfors MT, Neuvonen PJ. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine. Eur J Clin Pharmacol. 2006 ;62:451-461.
Block KI, Gyllenhaal C. Clinical corner: herb-drug interactions in cancer chemotherapy:
theoretical concerns regarding drug metabolizing enzymes. Integr Cancer Ther.
2002;1:83-89
Bock, KW, Surchell, B., Ditton, G.J., Hanninen, O., Mulder, G.J., Owens, I.S., Siest, G.
and Tephyl, T.R.. UDP-Glucuronosyl transferase activities: guidelines for consistent interim terminology and assay condition. Biochem. Pharmacol.
1983;32:953-955.
Brobst DE, Ding X, Creech KL, Goodwin B, Kelley B, Staudinger JL. Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor. J Pharmacol Exp Ther. 2004;310:528-535
Dahan A, Altman H. Food-drug interaction: grapefruit juice augments drug
bioavailability--mechanism, extent and relevance. European Journal of Clinical Nutrition 2004;58:1–9.
Dostalek M, Pistovcakova J, Jurica J, Tomandl J, Linhart I, Sulcova A, Hadasova E. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver. Lif Sci. 2005;78:239-244
Gaganis P, Miners JO, Knights KM. Glucuronidation of fenamates: Kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7. Biochem Pharmacol. 2007;73:1683-1691.
Grancharov K, Naydenova Z, Lozeva S, Golovinsky E. Natural and synthetic inhibitors of UDP-glucuronosyltransferase. Pharmacol. Ther. 2001;89:171-186.
Greenlee WF and Poland A. An improved assay of 7-ethoxycoumarin O-deethylation activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbiral, 3-methylcholanthrene, and 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. J.
Pharmacaol. Exp. Ther. 1978;205:596-605.
Guengerich, FP, Martin, M.V., Beaune, P.H., Kremers, P., Wolff, T. and Waxman, D.V..
Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J.
Biol. Chem. 1986;261:5051-5060.
Habig WH and Jakoby WB. Assays for differentiation of glutathione-S-transferase.
Method. Enzymol. 1981;77:398-405.
Harper PA, Wong JY, Lam MS, Okey AB. Polymorphisms in the human AH receptor.
Chem Biol Interact. 2002;141:161-187
Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005;45:51-88.
Kakizaki S, Yamamoto Y, Ueda A, Moore R, Sueyoshi T, Negishi M. Phenobarbital induction of drug/steroid-metabolizing enzymes and nuclear receptor CAR. Biochimica et Biophysica Acta 2003;1619:239-242.
Kim JH, Ryu YB, Kang NS, Lee BW, Heo JS, Jeong IY, Park KH. Glycosidase inhibitory flavonoids from Sophora flavescens. Biological and Pharmaceutical Bulletin
2006;29:302-305.
Kim EJ, Suh OK, Lee MG. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats. Life Sci. 2003 31;72:1231-1245.
Knodell RG, Hall SD, Willkinson GR and Guengerich FP. Hepatic metabolism of tolbutamide: characterization of form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J. Pharmacol. Exp. Ther.
1987;241:1112-1119.
Ko WG, Kang TH, Kim NY, Lee SJ, Kim YC, Ko GI, Ryu SY, and Lee BH.
Lavandulylflavonoids: a new class of in vitro apoptogenic agents from Sophora flavescens.
Toxicol In Vitro. 2000;14:429-33.
Kretschmer XC, Baldwin WS. CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact. 2005;155:111-128.
Kretz-Rommel A, Boelsterli UA. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediate acute cell injury in cultured rat hepatocyte. Toxicol. Appl. Pharmacol. 1993;120:155-161.
Krajk-Kuzniak V, Szaefer H, Baer-Dubowska W. Modulation of cytochrome P450 and phase II enzymes by protocatechuic acid in mouse liver and kidney. Toxicology 2005;216:24-31.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 1970;227:680-685.
Lim ST, Dragull K, Tang CS, Bittenbender HC, Efird JT, Nerurkar PV. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci. 2007;27.
Liu XF, Yuan H, Haniu M, Iyanagi T, Shively JE, and Chen S. Reaction of rat liver DT-diaphorase (NAD(P)H: quinine acceptor reductase) with
5’-[P-(fluorosulfonyl)benzoyl]adenosine. Mol. Pharmacol. 1989;35:818-822.
Lowry OH, Roseborough NJ, Farr AL, and Randall RL. Protein
measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265-275.
Lu C, and Li AP. Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. Chem Biol Interact.
2001;134:271-281.
Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T, and Guengerich FP.
Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem.
Biophys. 1985;238:43-48.
Mackenzie PI, Miners JO, Mckinnon RA. Polymorphisms in UDP-glucuronosyltransferase genes: functional consequences and clinical relevance. Clin. Chem. Lab. Med.
2000;38:889-892.
Masmoudi T, Hihi AK, Vazquez M, Artur Y, Desvergne B, Wahli W, Goudonnet H.
Transcriptional regulation by triiodothyronine of the UDP-glucuronosyltransferase family 1 gene complex in rat liver. Comparison with induction by 3-methylcholanthrene. J Biol Chem. 1997;272:17171-17175
McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25:1639-1648.
Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction.
Biochem. J. 1953;55: 416-421.
Nelson D. Cytochrome P450 and the individuality of species. Arch. Biochem. Biophys.
1999;369:1-10.
Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC, Nebert DW. P450 superfamily:
update on new sequences, gene mapping, accession numbers and nomenclature.
Pharmacogenetics 1996;6:1-42.
Omura T and Sato R. The carbon monoxide-binding pigment of liver microsomes. J. Biol.
Chem. 1964;239:2370-2379.
Phillips AH and Langdon RG. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J. Biol. Chem. 1962;237:
2652-2660.
Pohl RJ and Fouts JR. A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal. Biochem. 1980;107:150-155.
Reilly CH. Drugs facts and comparisons 60th Edition，822-826 （2006）
Roh SS, Kim CD, Lee MH, Hwang SL, Rang MJ, Yoon YK. The hair growth promoting effect of Sophora flavescens extract and its molecular regulation. Journal of
Dermatological Science 2002;30:43-49
Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP. Detection of DNA adducts fromed by aristolochic acid in renal tissue from patients with Chinese herbs nephrophathy. Cancer Research 1996;56:2025-2028.
Souček P. Novel sensitive high-performance liquid chromatographic method for assay of coumarin 7-hydroxylation. J. Chromatogr. B. 1999;734:23-29.
Telting-Diaz M, Scott DO, Lunte CE. Intravenous microdialysis sampling in awake, freely-moving rats. Anal Chem. 1992;64:806-10.
Towbin H, Staehelin T, and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl.
Acad. Sci. USA. 1979;76:4350-4354.
Tsoutsikos P, Miners JO, Stapleton A, Thomas A, Sallustio BC, Knights KM. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochem Pharmacol. 2004;67:191-199.
Ueng YF, Wang JJ, Lin LC, Park SS, Chen CF. Induction of cytochrome P450-dependent monooxygenase in mouse tissues by rutaecarpine. Life Sci., 2001;70:207-217.
Ueng YF, Hsieh CH, Don MJ, Chi CW, Ho LK. Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation. Chem. Res. Toxicol.;
2004;17:1151-1156.
Waxman DJ. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys. 1999;369:11-23.
Xu GL, Yao L, Rao SY, Gong ZN, Zhang SQ, Yu SQ. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase. Journal of Ethnopharmacology 2005;98:177-183.
Yamazaki H and Shimada T. Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Biochem. Pharmacol.
1997a;54:1195-1203.
Yasar U, Tybring G, Hidestrand M, Oscarson M, Ingelman-Sundberg M, Dahl ML, Eliasson E. Role of CYP2C9 polymorphism in losartan oxidation. Drug Metabolism and Disposition 2001;29:1051-1056.
Zuber R, Anzenbacherová E, Anzenbacher P. Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med. 2002;6:189-198.
（A）
（B）
Scheme 1.The pictures of kushen. （A）Sophora flavescens and（B）Sophora radix